HBV mutation literature information.


  Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.
 PMID: 25593470       2015       World journal of gastroenterology
Abstract: METHODS: The proportion of pre-core (G1896A) and basal core promoter (A1762T and G1764A) mutant viruses and serum levels of hepatitis B virus (HBV) DNA, hepatitis B surface antigen (HBsAg), and HB core-related antigen were analyzed in chronic hepatitis B patients before and after HBeAg seroconversion (n = 25), in those who were persistently HBeAg positive (n = 18), and in those who were persistently anti-HBe positive (n = 43).


  Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53.
 PMID: 25567052       2015       Digestive diseases and sciences
Abstract: METHODS: A HBx combination (combo) mutant with changes in the CP region that corresponded to A1762T/G1764A (TA), T1753A, and T1768A was constructed and expressed in L-02 and Hep3B cells.


  Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.
 PMID: 24406435       2015       Journal of clinical gastroenterology
Abstract: METHODS: We assessed serum HBeAg, HBV DNA levels, alanine transferase (ALT) levels, and progression of liver fibrosis in 226 Korean CHB patients, presumed to be infected with genotype C HBV, to analyze HBV variants in the preC region (G1896A) and CP regions (A1762T, G1764A).


  Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers.
 PMID: 24763132       2015       Gut
Abstract: BACKGROUND AND OBJECTIVE: Precore (PC) variant (G1896A) and basal core promoter (BCP) variant (A1762T/G1764A) of HBV are associated with risk of hepatocellular carcinoma in HBV carriers.


  Occult hepatitis B virus infection with positive hepatitis B e antigen.
 PMID: 25218700       2015       Clinica chimica acta; international journal of clinical chemistry
Abstract: The HBV had double mutations (A1762T and G1764A) in the basal core promoter but had no mutation in the pre C/C gene in both patients.


  Correlation between the promoter basal core and precore mutations and HBsAg quantification in French blood donors infected with hepatitis B virus.
 PMID: 25170961       2015       Journal of medical virology
Abstract: Direct sequencing of precore/core gene was used to detect A1762T/G1764A mutations in the BCP and G1896A in the PC region.


  Significance of mutations in hepatitis B virus X gene for the pathogenesis of HB-associated glomerulonephritis.
 PMID: 25283864       2014       Acta virologica
Abstract: In HBV-GN patients, missense nucleotide mutations of C1653T, A1726C, A1727T, C1730G, T1753C, A1762T, and G1764A were detected in 84% of subjects, all located in the trans-acting regulatory region of the X gene.


  Variability in the precore and core promoter region of the hepatitis B virus genome.
 PMID: 24249691       2014       Journal of medical virology
Abstract: The study confirmed that core promoter and precore mutations occur at key positions (A1762T, G1764A, G1896A, and G1899A), and that the proportions of strains with seroconvertion in patients differ between the four HBV genotypes.


  Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma.
 PMID: 24338810       2014       Journal of medical virology
Abstract: Core promoter T1753V, A1762T, and G1764A mutations were more frequent in patients with HCC than in those without, although with no statistical difference.


  Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
 PMID: 24344773       2014       Journal of viral hepatitis
Abstract: Accumulation of eight key mutations located in the X/preC regions of the hepatitis B virus (HBV) genome (G1613A, C1653T, T1753V, A1762T, G1764A, A1846T, G1896A and G1899A) is a risk marker for the development of hepatocellular carcinoma (HCC).
Abstract: Analyses were focused on patient >=40 years of age infected by HBV genotype C with A1762T and G1764A mutations in the basal core promoter region (<



Browser Board

 Co-occurred Entities




   Filtrator